Carlos A. Trujillo
Chief Financial OfficerMr. Carlos A. Trujillo, C.P.A., has been Chief Financial Officer of PharmaCyte Biotech, Inc. since March 2017 and was Director of PharmaCyte Biotech since March 2017 until August 2022. He has began working for PharmaCyte Biotech as an Independent Contractor since September 2014. In January 2015, Mr. Trujillo became a full-time employee as the Vice President of Finance of Viridis Biotech. He has experience in finance, accounting and management. Mr. Trujillo experience in management, business, operations and financial accounting. He served as Vice President of Finance of PharmaCyte Biotech, Inc. from January 2015 to March 2017. From June 2008 through September 2014, Mr. Trujillo was the Chief Financial Officer of VelaTel Global Communications, Inc. and also served its Chief Accounting Officer and Controller. Mr. Trujillo started his career in public accounting and was the manager of an audit department a large regional public accounting firm. Mr. Trujillo then established a consulting and accounting practice which he operated for ten years and provided services as the Chief Financial Accountant to numerous organizations in several different industries. His experience has extended to companies in the biotechnology, telecommunications, manufacturing, construction and real estate development sectors. He is a Certified Public Accountant licensed by the State of California. Mr. Trujillo received his Bachelors Degree in Accounting from California State University, Fullerton in 1982.
Positions
- Company NamePharmaCyte Biotech, Inc.Stock CodePMCBPositionChief Financial OfficerColleagues
- JNJoshua N. SilvermanCEO. President & Executive Chairman
- JLJose L. IglesiasConsulting Chief Medical Officer
- HHHans-Peter HammesMember of Medical & Scientific Advisory Board and Consultant
- MLMatthias LöhrChairman of Medical & Scientific Advisory Board
- JLJonathan L. SchechterIndependent Director
- RWRobert WeinsteinIndependent Director
